ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,635Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 617

$551K Total Retail Price of All Prescriptions

Rank: 67 out of 617

605 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 605 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 605 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 18,624 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$28 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
FUROSEMIDE 1,004 997 1 4
OMEPRAZOLE 891 851 2 3
LEVOTHYROXINE SODIUM 641 634 3 1
AMLODIPINE BESYLATE 616 585 4 6
CITALOPRAM HBR 541 533 5 18
METOPROLOL SUCCINATE 482 470 6 12
HYDROCODONE-ACETAMINOPHEN 398 384 S3 7 8
PRAVASTATIN SODIUM 362 347 8 21
SIMVASTATIN 335 321 9 2
LISINOPRIL 319 307 10 5
HYDROCHLOROTHIAZIDE 312 307 11 13
TRIAMTERENE-HCTZ 311 288 12 47
METFORMIN HCL 302 270 13 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 301 295 14 29
WARFARIN SODIUM 293 283 15 7
METOCLOPRAMIDE HCL 274 274 16 125
SPIRONOLACTONE 273 273 17 42
MIRTAZAPINE 265 265 18 50
CARVEDILOL 248 248 19 19
BISOPROLOL-HYDROCHLOROTHIAZIDE 244 229 20 87
PREDNISONE 232 231 21 31
ALLOPURINOL 207 187 22 27
GLIMEPIRIDE 199 173 23 33
AMITRIPTYLINE HCL 198 195 R 24 56
POTASSIUM CHLORIDE 182 182 25 10
LOSARTAN POTASSIUM 178 178 26 22
DOXAZOSIN MESYLATE 177 175 27 79
MELOXICAM 172 169 28 24
ZOLPIDEM TARTRATE 164 161 29 23
LOSARTAN-HYDROCHLOROTHIAZIDE 163 137 30 46
TRAMADOL HCL 163 131 30 15
METOPROLOL TARTRATE 162 158 32 11
GABAPENTIN 159 146 33 16
ROPINIROLE HCL 158 116 34 66
POLYETHYLENE GLYCOL 3350 157 157 35 32
SERTRALINE HCL 151 151 36 20
LOVASTATIN 149 145 37 57
BYSTOLIC 147 127 38 64
CARBIDOPA-LEVODOPA 147 129 38 69
BISOPROLOL FUMARATE 145 145 40 100
ENALAPRIL MALEATE 142 142 41 34
TRAZODONE HCL 141 141 42 51
TRAMADOL HCL-ACETAMINOPHEN 137 129 43 199
AMIODARONE HCL 136 136 44 129
TAMSULOSIN HCL 132 126 45 26
NORTRIPTYLINE HCL 129 111 46 191
ATENOLOL 115 110 47 17
COLESTIPOL HCL 113 112 48 190
GEMFIBROZIL 113 99 48 105
RISPERIDONE 106 87 50 71
CLONIDINE HCL 104 76 51 55
DIOVAN HCT 98 98 52 97
VENLAFAXINE HCL ER 95 82 53 76
PAROXETINE HCL 94 90 54 62
OXYBUTYNIN CHLORIDE 94 93 54 88
PROPRANOLOL HCL 94 94 54 109
DILTIAZEM 24HR CD 93 93 57 117
ATORVASTATIN CALCIUM 89 89 58 14
FENTANYL 86 86 S2 59 45
DIGOXIN 85 85 60 48
DIVALPROEX SODIUM 76 76 61 111
DONEPEZIL HCL 76 76 61 30
BUPROPION HCL SR 75 72 63 202
DIOVAN 75 63 63 41
METHYLPHENIDATE HCL 72 59 65 215
QUETIAPINE FUMARATE 71 60 66 78
CLOPIDOGREL 70 63 67 53
METHOTREXATE 69 69 68 250
MECLIZINE HCL 69 69 68 150
DOXEPIN HCL 66 66 70 216
TRIAMCINOLONE ACETONIDE 66 63 70 102
FAMOTIDINE 65 65 72 54
VYTORIN 64 54 73 160
DETROL LA 64 59 73 127
ESCITALOPRAM OXALATE 63 45 75 65
ALENDRONATE SODIUM 61 58 76 25
PLAVIX 61 56 76 86
SUCRALFATE 58 56 78 143
FINASTERIDE 56 56 79 104
DICLOFENAC SODIUM 55 55 80 98
BENAZEPRIL HCL 53 51 81 44
SPIRIVA 51 51 82 61
AMLODIPINE BESYLATE-BENAZEPRIL 51 47 82 80
FLUOXETINE HCL 50 46 84 73
CRESTOR 50 40 84 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.